Switch theme
Sign up to access all valuation multiples
Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.
2010
23
LTM Revenue $0.1M
LTM EBITDA -$5.5M
$61.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Amoeba has a last 12-month revenue of $0.1M and a last 12-month EBITDA of -$5.5M.
In the most recent fiscal year, Amoeba achieved revenue of n/a and an EBITDA of -$14.1M.
Amoeba expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amoeba valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | XXX | XXX | XXX |
| Gross Profit | -$0.8M | -$1.2M | XXX | XXX | XXX |
| Gross Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| EBITDA | -$5.7M | -$14.1M | XXX | XXX | XXX |
| EBITDA Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Profit | -$8.4M | -$8.6M | XXX | XXX | XXX |
| Net Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Debt | $5.1M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Amoeba's stock price is EUR 1 (or $1).
Amoeba has current market cap of EUR 48.6M (or $52.2M), and EV of EUR 57.3M (or $61.5M).
See Amoeba trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $61.5M | $52.2M | XXX | XXX | XXX | XXX | $-0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Amoeba has market cap of $52.2M and EV of $61.5M.
Amoeba's trades at 569.1x LTM EV/Revenue multiple, and -11.2x LTM EBITDA.
Analysts estimate Amoeba's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Amoeba and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $61.5M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | -4.4x | XXX | XXX | XXX |
| P/E | -3.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -4.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAmoeba's NTM/LTM revenue growth is 1305%
Amoeba's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Amoeba's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Amoeba's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Amoeba and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | 145% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Hydratec Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| Brazil Potash | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers & Chemicals | XXX | XXX | XXX | XXX | XXX | XXX |
| Biotalys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amoeba acquired XXX companies to date.
Last acquisition by Amoeba was XXXXXXXX, XXXXX XXXXX XXXXXX . Amoeba acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Amoeba founded? | Amoeba was founded in 2010. |
| Where is Amoeba headquartered? | Amoeba is headquartered in France. |
| How many employees does Amoeba have? | As of today, Amoeba has 23 employees. |
| Is Amoeba publicy listed? | Yes, Amoeba is a public company listed on PAR. |
| What is the stock symbol of Amoeba? | Amoeba trades under ALMIB ticker. |
| When did Amoeba go public? | Amoeba went public in 2015. |
| Who are competitors of Amoeba? | Similar companies to Amoeba include e.g. Fertiglobe, Hydratec Industries, Brazil Potash, Gujarat State Fertilizers & Chemicals. |
| What is the current market cap of Amoeba? | Amoeba's current market cap is $52.2M |
| What is the current revenue of Amoeba? | Amoeba's last 12-month revenue is $0.1M. |
| What is the current EBITDA of Amoeba? | Amoeba's last 12-month EBITDA is -$5.5M. |
| What is the current EV/Revenue multiple of Amoeba? | Current revenue multiple of Amoeba is 569.1x. |
| What is the current EV/EBITDA multiple of Amoeba? | Current EBITDA multiple of Amoeba is -11.2x. |
| Is Amoeba profitable? | Yes, Amoeba is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
